Pakistan's pharmaceutical industry is moving towards new heights of growth due to the support of Special Investment Facilitation Council (SIFC).

The profits of pharmaceutical sector reached a record high of 42.2 billion last year, marking a seventy-eight percent increase.

Following deregulation, improved pricing and lower costs enabled the sector to achieve record profits.

Net sales of the pharma sector rose by fourteen percent to 365.7 billion rupees last year due to better pricing.